Loss of the type Ill TGF-β receptor during cancer progression generates an immunotolerant tumor microenvironment: Translational implications for TGF-β inhibition and immunotherapy biomarker development

被引：0
|
作者：
Hanks, Brent A. [1 ]
Holtzhausen, Alisha [1 ]
Gimpel, Petra [2 ]
Campbell, Olivia [1 ]
Jamieson, Rebekah [1 ]
Ling, Leona E. [3 ]
Morse, Michael A. [1 ]
Lyerly, H. K. [1 ]
Blobe, Gerard [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Free Univ Berlin, Berlin, Germany
[3] Biogen Idec Inc, Cambridge, MA USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-3548
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3548
引用
下载
收藏
页数：1
相关论文
共 45 条
  • [1] Type III TGF-β receptor downregulation generates an immunotolerant tumor microenvironment
    Hanks, Brent A.
    Holtzhausen, Alisha
    Evans, Katherine S.
    Jamieson, Rebekah
    Gimpel, Petra
    Campbell, Olivia M.
    Hector-Greene, Melissa
    Sun, Lihong
    Tewari, Alok
    George, Amanda
    Starr, Mark
    Nixon, Andrew
    Augustine, Christi
    Beasley, Georgia
    Tyler, Douglas S.
    Osada, Takayu
    Morse, Michael A.
    Ling, Leona
    Lyerly, H. Kim
    Blobe, Gerard C.
    JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (09): : 3925 - 3940
  • [2] Effect of the loss of the type III TGFβ receptor during tumor progression on tumor microenvironment: Preclinical development of TGFβ inhibition and TGFβ-related biomarkers to enhance immunotherapy efficacy.
    Hanks, Brent Allen
    Holtzhausen, Alisha
    Gimpel, Petra
    Jamieson, Rebekah
    Campbell, Olivia M.
    Sun, Lihong
    Augustine, Christina K.
    Tyler, Douglas S.
    Osada, Takuya
    Morse, Michael
    Ling, Leona E.
    Lyerly, H. Kim
    Blobe, Gerard C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] The type III TGF-β receptor suppresses breast cancer progression through GIPC-mediated inhibition of TGF-β signaling
    Lee, Jason D.
    Hempel, Nadine
    Lee, Nam Y.
    Blobe, Gerard C.
    CARCINOGENESIS, 2010, 31 (02) : 175 - 183
  • [4] The type III TGF-β receptor suppresses breast cancer progression
    Dong, Mei
    How, Tam
    Kirkbride, Kellye C.
    Gordon, Kelly J.
    Lee, Jason D.
    Hempel, Nadine
    Kelly, Patrick
    Moeller, Benjamin J.
    Marks, Jeffrey R.
    Blobe, Gerard C.
    JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (01): : 206 - 217
  • [5] Transforming of the Tumor Microenvironment: Implications for TGF- Inhibition in the Context of Immune-Checkpoint Therapy
    Loeffek, Stefanie
    JOURNAL OF ONCOLOGY, 2018, 2018
  • [6] Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression
    Jones, Elisabeth
    Pu, Hong
    Kyprianou, Natasha
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2009, 13 (02) : 227 - 234
  • [7] Long lasting inhibition of TGF-β receptor Type 1 inhibitor (TGF-β R1) for treatment of pancreatic cancer
    Rodriguez-Aguayo, Cristian
    Bayraktar, Emine
    Shen, Haifa
    Lopez-Berestein, Gabriel
    CANCER RESEARCH, 2017, 77
  • [8] Switching Roles of TGF-β in Cancer Development: Implications for Therapeutic Target and Biomarker Studies
    Sun, Nan
    Taguchi, Ayumu
    Hanash, Samir
    JOURNAL OF CLINICAL MEDICINE, 2016, 5 (12):
  • [9] The dual roles of calycosin in growth inhibition and metastatic progression during pancreatic cancer development: A "TGF-β paradox"
    Zhang, Zhu
    Auyeung, Kathy Ka-Wai
    Sze, Stephen Cho-Wing
    Zhang, Shiqing
    Yung, Ken Kin-Lam
    Ko, Joshua Ka-Shun
    PHYTOMEDICINE, 2020, 68
  • [10] Ontogeny and localization of TGF-β type I receptor expression during lung development
    Zhao, Y
    Young, SL
    McIntosh, JC
    Steele, MP
    Silbajoris, R
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2000, 278 (06) : L1231 - L1239
12345